VU0810464, a non-urea G protein-gated inwardly rectifying K+ (Kir3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir3 channels and reduces stress-induced hyperthermia in mice

Baovi N. Vo, Kristopher K. Abney, Allison Anderson, Ezequiel Marron Fernandez de Velasco, Michael A. Benneyworth, John Scott Daniels, Ryan D. Morrison, Corey R Hopkins, Charles David Weaver, Kevin Wickman

Research output: Contribution to journalArticle

Abstract

Background and Purpose: G protein-gated inwardly rectifying K+ (Kir3) channels moderate the activity of excitable cells and have been implicated in neurological disorders and cardiac arrhythmias. Most neuronal Kir3 channels consist of Kir3.1 and Kir3.2 subtypes, while cardiac Kir3 channels consist of Kir3.1 and Kir3.4 subtypes. Previously, we identified a family of urea-containing Kir3 channel activators, but these molecules exhibit suboptimal pharmacokinetic properties and modest selectivity for Kir3.1/3.2 relative to Kir3.1/3.4 channels. Here, we characterize a non-urea activator, VU0810464, which displays nanomolar potency as a Kir3.1/3.2 activator, improved selectivity for neuronal Kir3 channels, and improved brain penetration. Experimental Approach: We used whole-cell electrophysiology to measure the efficacy and potency of VU0810464 in neurons and the selectivity of VU0810464 for neuronal and cardiac Kir3 channel subtypes. We tested VU0810464 in vivo in stress-induced hyperthermia and elevated plus maze paradigms. Parallel studies with ML297, the prototypical activator of Kir3.1-containing Kir3 channels, were performed to permit direct comparisons. Key Results: VU0810464 and ML297 exhibited comparable efficacy and potency as neuronal Kir3 channel activators, but VU0810464 was more selective for neuronal Kir3 channels. VU0810464, like ML297, reduced stress-induced hyperthermia in a Kir3-dependent manner in mice. ML297, but not VU0810464, decreased anxiety-related behaviour as assessed with the elevated plus maze test. Conclusion and Implications: VU0810464 represents a new class of Kir3 channel activator with enhanced selectivity for Kir3.1/3.2 channels. VU0810464 may be useful for examining Kir3.1/3.2 channel contributions to complex behaviours and for probing the potential of Kir3 channel-dependent manipulations to treat neurological disorders.

Original languageEnglish (US)
Pages (from-to)2238-2249
Number of pages12
JournalBritish Journal of Pharmacology
Volume176
Issue number13
DOIs
StatePublished - Jul 1 2019

Fingerprint

Induced Hyperthermia
Nervous System Diseases
GTP-Binding Proteins
Inwardly Rectifying Potassium Channel
Electrophysiology
Urea
Cardiac Arrhythmias
Anxiety
Pharmacokinetics
Neurons
Brain

ASJC Scopus subject areas

  • Pharmacology

Cite this

VU0810464, a non-urea G protein-gated inwardly rectifying K+ (Kir3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir3 channels and reduces stress-induced hyperthermia in mice. / Vo, Baovi N.; Abney, Kristopher K.; Anderson, Allison; Marron Fernandez de Velasco, Ezequiel; Benneyworth, Michael A.; Daniels, John Scott; Morrison, Ryan D.; Hopkins, Corey R; Weaver, Charles David; Wickman, Kevin.

In: British Journal of Pharmacology, Vol. 176, No. 13, 01.07.2019, p. 2238-2249.

Research output: Contribution to journalArticle

Vo, Baovi N. ; Abney, Kristopher K. ; Anderson, Allison ; Marron Fernandez de Velasco, Ezequiel ; Benneyworth, Michael A. ; Daniels, John Scott ; Morrison, Ryan D. ; Hopkins, Corey R ; Weaver, Charles David ; Wickman, Kevin. / VU0810464, a non-urea G protein-gated inwardly rectifying K+ (Kir3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir3 channels and reduces stress-induced hyperthermia in mice. In: British Journal of Pharmacology. 2019 ; Vol. 176, No. 13. pp. 2238-2249.
@article{06a0c4adfd0d4222b363a9e8d7889385,
title = "VU0810464, a non-urea G protein-gated inwardly rectifying K+ (Kir3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir3 channels and reduces stress-induced hyperthermia in mice",
abstract = "Background and Purpose: G protein-gated inwardly rectifying K+ (Kir3) channels moderate the activity of excitable cells and have been implicated in neurological disorders and cardiac arrhythmias. Most neuronal Kir3 channels consist of Kir3.1 and Kir3.2 subtypes, while cardiac Kir3 channels consist of Kir3.1 and Kir3.4 subtypes. Previously, we identified a family of urea-containing Kir3 channel activators, but these molecules exhibit suboptimal pharmacokinetic properties and modest selectivity for Kir3.1/3.2 relative to Kir3.1/3.4 channels. Here, we characterize a non-urea activator, VU0810464, which displays nanomolar potency as a Kir3.1/3.2 activator, improved selectivity for neuronal Kir3 channels, and improved brain penetration. Experimental Approach: We used whole-cell electrophysiology to measure the efficacy and potency of VU0810464 in neurons and the selectivity of VU0810464 for neuronal and cardiac Kir3 channel subtypes. We tested VU0810464 in vivo in stress-induced hyperthermia and elevated plus maze paradigms. Parallel studies with ML297, the prototypical activator of Kir3.1-containing Kir3 channels, were performed to permit direct comparisons. Key Results: VU0810464 and ML297 exhibited comparable efficacy and potency as neuronal Kir3 channel activators, but VU0810464 was more selective for neuronal Kir3 channels. VU0810464, like ML297, reduced stress-induced hyperthermia in a Kir3-dependent manner in mice. ML297, but not VU0810464, decreased anxiety-related behaviour as assessed with the elevated plus maze test. Conclusion and Implications: VU0810464 represents a new class of Kir3 channel activator with enhanced selectivity for Kir3.1/3.2 channels. VU0810464 may be useful for examining Kir3.1/3.2 channel contributions to complex behaviours and for probing the potential of Kir3 channel-dependent manipulations to treat neurological disorders.",
author = "Vo, {Baovi N.} and Abney, {Kristopher K.} and Allison Anderson and {Marron Fernandez de Velasco}, Ezequiel and Benneyworth, {Michael A.} and Daniels, {John Scott} and Morrison, {Ryan D.} and Hopkins, {Corey R} and Weaver, {Charles David} and Kevin Wickman",
year = "2019",
month = "7",
day = "1",
doi = "10.1111/bph.14671",
language = "English (US)",
volume = "176",
pages = "2238--2249",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "13",

}

TY - JOUR

T1 - VU0810464, a non-urea G protein-gated inwardly rectifying K+ (Kir3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir3 channels and reduces stress-induced hyperthermia in mice

AU - Vo, Baovi N.

AU - Abney, Kristopher K.

AU - Anderson, Allison

AU - Marron Fernandez de Velasco, Ezequiel

AU - Benneyworth, Michael A.

AU - Daniels, John Scott

AU - Morrison, Ryan D.

AU - Hopkins, Corey R

AU - Weaver, Charles David

AU - Wickman, Kevin

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Background and Purpose: G protein-gated inwardly rectifying K+ (Kir3) channels moderate the activity of excitable cells and have been implicated in neurological disorders and cardiac arrhythmias. Most neuronal Kir3 channels consist of Kir3.1 and Kir3.2 subtypes, while cardiac Kir3 channels consist of Kir3.1 and Kir3.4 subtypes. Previously, we identified a family of urea-containing Kir3 channel activators, but these molecules exhibit suboptimal pharmacokinetic properties and modest selectivity for Kir3.1/3.2 relative to Kir3.1/3.4 channels. Here, we characterize a non-urea activator, VU0810464, which displays nanomolar potency as a Kir3.1/3.2 activator, improved selectivity for neuronal Kir3 channels, and improved brain penetration. Experimental Approach: We used whole-cell electrophysiology to measure the efficacy and potency of VU0810464 in neurons and the selectivity of VU0810464 for neuronal and cardiac Kir3 channel subtypes. We tested VU0810464 in vivo in stress-induced hyperthermia and elevated plus maze paradigms. Parallel studies with ML297, the prototypical activator of Kir3.1-containing Kir3 channels, were performed to permit direct comparisons. Key Results: VU0810464 and ML297 exhibited comparable efficacy and potency as neuronal Kir3 channel activators, but VU0810464 was more selective for neuronal Kir3 channels. VU0810464, like ML297, reduced stress-induced hyperthermia in a Kir3-dependent manner in mice. ML297, but not VU0810464, decreased anxiety-related behaviour as assessed with the elevated plus maze test. Conclusion and Implications: VU0810464 represents a new class of Kir3 channel activator with enhanced selectivity for Kir3.1/3.2 channels. VU0810464 may be useful for examining Kir3.1/3.2 channel contributions to complex behaviours and for probing the potential of Kir3 channel-dependent manipulations to treat neurological disorders.

AB - Background and Purpose: G protein-gated inwardly rectifying K+ (Kir3) channels moderate the activity of excitable cells and have been implicated in neurological disorders and cardiac arrhythmias. Most neuronal Kir3 channels consist of Kir3.1 and Kir3.2 subtypes, while cardiac Kir3 channels consist of Kir3.1 and Kir3.4 subtypes. Previously, we identified a family of urea-containing Kir3 channel activators, but these molecules exhibit suboptimal pharmacokinetic properties and modest selectivity for Kir3.1/3.2 relative to Kir3.1/3.4 channels. Here, we characterize a non-urea activator, VU0810464, which displays nanomolar potency as a Kir3.1/3.2 activator, improved selectivity for neuronal Kir3 channels, and improved brain penetration. Experimental Approach: We used whole-cell electrophysiology to measure the efficacy and potency of VU0810464 in neurons and the selectivity of VU0810464 for neuronal and cardiac Kir3 channel subtypes. We tested VU0810464 in vivo in stress-induced hyperthermia and elevated plus maze paradigms. Parallel studies with ML297, the prototypical activator of Kir3.1-containing Kir3 channels, were performed to permit direct comparisons. Key Results: VU0810464 and ML297 exhibited comparable efficacy and potency as neuronal Kir3 channel activators, but VU0810464 was more selective for neuronal Kir3 channels. VU0810464, like ML297, reduced stress-induced hyperthermia in a Kir3-dependent manner in mice. ML297, but not VU0810464, decreased anxiety-related behaviour as assessed with the elevated plus maze test. Conclusion and Implications: VU0810464 represents a new class of Kir3 channel activator with enhanced selectivity for Kir3.1/3.2 channels. VU0810464 may be useful for examining Kir3.1/3.2 channel contributions to complex behaviours and for probing the potential of Kir3 channel-dependent manipulations to treat neurological disorders.

UR - http://www.scopus.com/inward/record.url?scp=85066495959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066495959&partnerID=8YFLogxK

U2 - 10.1111/bph.14671

DO - 10.1111/bph.14671

M3 - Article

VL - 176

SP - 2238

EP - 2249

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 13

ER -